Enterprise League logo

Biotechnology Companies in Europe

Biotechnology companies develop, manufacture, and distribute medical devices, diagnostics, or pharmaceutical products for use in clinical, hospital, and research settings. This page lists companies operating in the Biotechnology sector based on self-reported profile data. The directory currently holds 480 companies in this sector. The largest share of listings is based in London. Related sectors on Enterprise League include Medical Equipment and Services, Life Science, Genetics, Pharmaceutical, Biopharma, Clinical Trials, Nanotechnology.
480 companies
London top city

Europe
Biotechnology
List of Biotechnology companies in Europe

480 companies

Sort by

Resolve Biosciences is applying the power of Molecular Cartography™ to enable scientists to gain new insights based on the highest-resolution view of single-cell spatial biology. The platform features the company's proprietary, multiplexed, single-molecule detection technology, which offers full spatial context at subcellular resolution, all in a workflow that preserves the sample tissue. The platform offers unparalleled sensitivity and specificity that helps scientists detect individual transcripts and rare signals to interpret fundamental biology and rapidly advance the understanding of complex biological questions in critical fields such as oncology, neuroscience, and infectious disease. The technology has been under development since 2016 and is currently available through an oversubscribed early access program.
Biotechnology

2020

We specialise in producing sustainable plant extracts with proven health benefits. Our expert team conducts through research and development to deliver high-performance, top-quality solutions across diverse industries. Our products are upheld to a level of quality that exceeds the most rigorous standards in the industry. Plant sources are certified additionally through HABOID, a proprietary analytical method, which guarantees the purest botanical products possible. Sustainability is integral to our business model. Natac systematically analyses agricultural processes throughout the botanical industry to discover points in production that have the potential for intervention and investment. Our goal is to use the whole plant in order to access its full potential and thereby reduce the environmental impact of production. Internationally present with established markets around the world, Natac maintains the strategic location of our manufacturing, R&D and Innovation Unit, and Quality Department in Spain, which secures European standards.
Biotechnology

2010

Cellomatics Biosciences Ltd. (www.cellomaticsbio.com) is a laboratory-based Contract Research Organisation (CRO) specialised in Oncology/Immuno-Oncology, Immunology/Inflammation and Respiratory therapeutic areas. Based at Colwick Quays Business Park, Nottingham UK, our experienced scientific team offers bespoke and innovative preclinical in vitro bioassay services to support our client’s drug development programmes. We work with diverse group of global clients including early start-ups, virtual/small to medium sized Biotechnology and Pharmaceutical companies.
Biotechnology

2015

Concept Life Sciences is a knowledge-based, science-led and customer-focused contract research and manufacturing organisation with world-leading expertise in the pharmaceutical, biotech and agrochemical industries. We are based across 5 sites in the UK delivering discovery research as well as GMP, GLP and GCP-regulated work. Whether it is delivering whole programs of research or bespoke studies we deliver a collaborative client-centred approach. Our services are built on scientist-to-scientist engagement, deep knowledge, flexibility and extensive in-house resources. Our services span and can scale to every stage from discovery to development: ✔️ Discovery chemistry ✔️ Immunology, immuno-oncology and neuroscience ✔️ Analytical services, including materials characterisation and physicochemical analysis ✔️ Process research and development ✔️ GMP manufacturing
Biotechnology

2014

🔵 What do we do? Multus is reinventing growth media for cell culture in cultivated meat and life science. From growth factors to serum-free supplements, we partner with companies looking for media breakthroughs to help accelerate their progress and de-risk their supply chain. 🔵 How do we do it better? We use a groundbreaking combination of data science, high-throughput automation and ISO-certified manufacturing to develop ingredients and formulations that reduce costs, eliminate animal-sourced components and enable scale-up. 🔵 Why do we do it? Our Mission is to make cultivated meat the sustainable and affordable choice, for everyone. To get there, every cultivated meat company needs to achieve the following growth media milestones: 1️⃣ Reduced input costs 2️⃣ Use of food-grade, animal-free ingredients that are sustainably sourced and aligned with regulation 3️⃣ Optimised formulations to improve bioprocess performance 4️⃣ Established scalable feedstocks where supply meets future production plans Companies that choose Multus see us as an indispensable partner in their journey to scaling cultivated meat production.
Biotechnology

2019

Eden Bio uses machine learning to improve protein yield, saving companies time and money, and helping them get their proteins to market faster.
Biotechnology

2021

Kyomei is a molecular farming and biotechnology start-up that focuses on the production of animal-identical proteins, pigments, ingredients and molecules using the power of plants, photosynthesis, and molecular biology. We aim to fundamentally transform agriculture and the food industry by decoupling the deleterious impact of animal agriculture from its byproducts and offering a more compelling, lower cost and sustainable means of production. Animal-identical benefits. Plant-grown production.
Biotechnology

2021

We are breaking down the barriers to safe and affordable universal stem cell therapies using our novel, broadly applicable and scalable purification platform.
Biotechnology

2024

We are on a mission to cure as many people as possible from disease - making the world stronger, together. We do this by empowering drug formulators to design new vaccines and therapeutics faster and make them more efficient by programming the quality and quantity of immunological responses. At iuvantium, we harness the power of cross disciplinary collaboration, cutting-edge technology, and ethical principles to revolutionize the field of immunotherapy. We strive to create a world where everyone, regardless of their background or circumstances, has access to the best healthcare. By merging immunology, AI, engineering principles, and materials science, we develop a scalable and cost-effective immune modulation platform. Our platform empowers immunotherapy developers to enhance the effectiveness of a vaccine/drug’s performance in real life settings and improve accessibility of their formulations, leading to breakthrough treatments for cancer and infectious diseases. We envision a future where the power of human compassion and collaboration transcends boundaries, making transformative healthcare solutions available to all. We aspire to be at the forefront of innovation in the field of immune therapies, revolutionizing the way diseases are treated and prevented. By decoding the intricacies of the immune system and harnessing the potential of inorganic materials, we pioneer novel approaches that shape the development of next-generation vaccines, cellular therapies, and drugs. Our vision is to serve as the catalyst for positive change, partnering with pharmaceutical companies to realize a world free from the shackles of cancer and infectious diseases. Through our work, we envision a future where preventable suffering is eradicated, lives are saved, and individuals are empowered to reach their fullest potential. Together, we will build a world where healthcare knows no boundaries and the human spirit.
Biotechnology

2023

Kerato Limited is pioneering the use of advanced tissue engineering technologies to develop biosynthetic, biosimilar corneas that have the potential to revolutionize corneal care for medical, research and commercial applications.
Biotechnology

2023

Since inception in 2002, Future Health Biobank has remained the largest and most pioneering UK stem cell bank, continuously setting standards for others to follow. We were the first private family bank in the UK to specialise in the processing, testing and long term storage of cord blood and cord tissue and since then, we have been entrusted with over 140,000 samples from more than 75,000 families from 75 countries. We have been certified and licensed by more regulators than any other stem cell bank. With two laboratories over two geographically separate locations and since incorporation we have been awarded a full HTA license, Swissmedic license, MHRA accreditation, AABB accreditation, and ISO 9001 certification. We are also the only UK family bank to have ever received the prestigious Queen’s Award for Enterprise.
Biotechnology

2002

Applied Photophysics, of Leatherhead, Surrey, UK, is a leading provider of solutions for the biophysical characterization of biomolecules and has been providing spectroscopy to the research community for over 50 years. Chirascan™ systems use the phenomenon of circular dichroism (CD) to characterize changes in the higher order structure of proteins. These systems are used in cutting-edge research and to support the development of innovator drugs and biosimilars in the biopharmaceutical industry. The company’s SX-range of stopped-flow spectrometers is acknowledged globally as the gold standard for kinetic studies of fast biochemical reactions. Through a joint venture with Fluorescence Innovations Inc of Minneapolis, MN, USA, operating as Protein Stable, we have also introduced easy-to-use high-throughput protein stability screening with microplate-based intrinsic fluorescence thermal ramping and chemical melt plate readers.
Biotechnology

1971

Cellbox Solutions is a young technology company focusing on delivering innovative and new solutions for the correct handling of living cells and biologic structures. Our product Cellbox is a self-sustaining carbon dioxide incubator supporting the appropriate storage, reproduction, transportation and analysis of biologic materials. The incubator’s temperature and gas environment can be adjusted based on the biosphere necessary for the cultivating cells stored.
Biotechnology

2017

We have developed an improved Monocyte Activation Test (MAT) for pyrogen testing. The MAT serves as the replacement for the Rabbit Pyrogen Test and can be used to test parenteral drugs for endotoxin and non-endotoxin contaminations. Our technology uses cryopreserved pooled PBMC. This has made it possible to develop a MAT with both high sensitivity and robustness, ensuring reliability in the field. Monocyte Activation Test (MAT) The Monocyte Activation Test (MAT) is a pyrogen test. MAT uses human blood cells to test for a fever reaction, mimicking the human immune reaction.The MAT serves as the replacement for the Rabbit Pyrogen Test and can be used to test parenteral drugs for endotoxin and non-endotoxin contaminations. Our technology uses cryopreserved pooled PBMC. This has made it possible to develop a MAT with both high sensitivity and robustness, ensuring reliability in the field. The MAT kit includes all the required consumables to perform the Monocyte Activation Test, making it convenient to perform. In addition to the kit we provide consulting services and technical support in setting up the MAT in your organisation.
Biotechnology

2016

PentaBase is a knowledge-based Danish pharmacogenomics company founded and managed by researchers and located in the heart of Denmark. We specialise in custom oligonucleotide production and the development of in vitro diagnostic assays for real-time PCR with a special focus on the detection of somatic mutations in cancer and COVID-19. For more than 10 years, PentaBase has created products for researchers and medical professionals exploring new treatments and helping patients worldwide. Our products are given unique abilities in the analysis and manipulation of genetic material with our proprietary technology, INAs® (Intercalating Nucleic Acids). Medical professionals and researchers use these features to help treat diseases and acquire new knowledge. We believe in open-platform designs and strive to make our products compatible with basic instruments used in molecular biology facilities worldwide. For more information, please contact us at: Tel: +45 3696 9496 Mail: info@pentabase.com https://www.pentabase.com/
Biotechnology

2006

Unseen Bio is introducing the groundbreaking product Digital Gut within the preventive healthcare industry. Your gut consists of a unique and vast ecosystem of microorganisms; the gut microbiome. Bacteria, viruses, and fungi thrive here and they are specialized in coexisting with you. Jointly they perform a variety of tasks that remarkably influence the health and wellbeing of their host - you. In the past, little attention has been paid to the gut microbiome but this new booming scientific field suggests the role of the microbiome as a means to prevent, predict and treat conditions in the bowel and other parts of the human body. Today understanding, maintaining, and optimizing your highly individual gut microbiome is the future for good health, wellbeing, and body performance. We unleash the health tech potential of stool data by analyzing the gut microbiota using next generation gut bacteria sequencing. Unseen Bio is a Danish biotech company.
Biotechnology

2018

ACIES BIO is a biotechnology contract research organization offering state-of-the-art R&D services to pharmaceutical, chemical, biotech and food industries. We provide full support from idea conceptualization through research to product development. Combining biotechnology and synthetic organic chemistry expertise, we offer a comprehensive service, covering all key development steps for efficient production of biosynthetic natural products or their semi-synthetic derivatives, as well as entirely synthetic compounds. Working with some of the largest international companies, we provide to our clients full R&D support both in our laboratories as well as on-site at the client’s facilities. With experience and know-how in natural product (bio)synthesis, milestone-based approach to projects, innovativeness and flexibility, as well as competitive pricing, ACIES BIO aims to become the premier partner in R&D outsourcing for pharmaceutical companies.
Biotechnology

2006

Founded in 2018, Abzu® is unlocking the future of drug discovery by transcending the limitations of black-box AI and ordinary analytics. Abzu established itself as a global leader in explainable AI and drug discovery by contributing to new discoveries in RNA therapeutics and disease understanding. Today, Abzu specializes in applying its expertise in siRNA, saRNA, ASOs, and anti-miRNA and its proprietary, explainable AI technology to build the future of RNA therapeutics.
Biotechnology

2018

2BScientific is a leading distributor of innovative life science products, serving customers in the UK, Europe, and worldwide. Our top priority is always the customer, and we go above and beyond to provide exceptional service and innovative products that support scientific discovery. From cutting-edge assays and technologies to reagents for basic research, we offer a wide range of innovative products that are designed to meet the needs of researchers across a variety of disciplines.
Biotechnology

2009

Bio-Cord pertenece al mayor grupo de laboratorios clínicos más avanzado de Europa. El grupo cuenta con 1.000 empleados, realizando al día hasta 20.000 análisis clínicos y con 75.000 unidades de cordón conservadas. 18 años de trayectoria conservando y procesando células madre bajo la mayor rigurosidad y las máximas acreditaciones de calidad del sector. En Bio-Cord invertimos en investigación y desarrollo de nuevas tecnologías y por ello ofrecemos los mejores y más completos servicios; con nosotros las células de tu bebé están en las mejores manos. Bio-Cord es el proveedor oficial seleccionado por las principales compañías de salud en España.
Biotechnology

2013

GeneS opera nel settore delle biotecnologie ed in particolare nella ricerca applicata delle tecnologie biomolecolari. GeneS vuole essere il tramite tra le esigenze di mercato e l’innovazione tecnologica nel settore Biotech, sviluppando progetti e prodotti market fit. Supportiamo professionisti del settore della nutrizione, healthcare, wellness, sport e della diagnostica per la salute. Offriamo una vasta gamma di analisi metagenomiche basate sul sequenziamento del DNA (tramite tecnologia NGS – Next Generation Sequencing) che permettono l’identificazione e la caratterizzazione di genomi e delle loro alterazioni responsabili di numerose patologie e che influiscono sullo stato di salute della persona.
Biotechnology

2019

Single Cell Discoveries is the leading single-cell sequencing CRO providing high-impact insights to biopharmaceutical companies, health systems, and academic research centers globally. We offer single-cell, spatial, and bulk transcriptomics. Our R&D team is actively developing novel single-cell sequencing technologies, multi-omic applications, and spatial transcriptomics.
Biotechnology

2018

Antibodies.com supplies high-quality antibodies, proteins, and ELISA kits to life science researchers at cost-effective prices. Headquartered in Cambridge (UK), and with offices in Stockholm (SE) and St Louis (MO, USA), we support life scientists worldwide by supplying the same high-quality products as the industry leading suppliers, that are sourced from the same primary manufacturers, but at more affordable prices. We can support your research with high-quality and characterized research tools, expert customer service, detailed product datasheets, and fast global delivery. Our growing product range caters for every discipline and includes: primary antibodies, secondary antibodies, ELISA kits, cell based assays, proteins and peptides, and other companion products. Discover more, for less.
Biotechnology

2015

SLS first began trading in 1991 and, since then, we have grown to become the UK’s largest independent supplier of laboratory equipment, chemicals and consumables. Because of our independence, we are unique in our approach to sourcing and supplying the highest quality, best value products and brands. We provide precisely what you need, when you need it, whether you’re searching for something specific or aiming to equip an entire laboratory. Whatever you are looking for, you can be sure our team will take care of you and provide a dedicated service that’s designed entirely around you and your business. From pipettes and petri dishes to the latest in laboratory instrumentation, we pride ourselves on the quality of products and the service we provide. In addition to manufacturing our own SLS Select consumable and chemical ranges, we partner with industry leading names including Sigma-Aldrich, Becton Dickinson, Eppendorf, Cytiva, DWK Life Sciences, Kimberly-Clark, Sartorius, Taylor Wharton, Thermo-Scientific, 3M and Corning. However specific your needs, you can be sure we’ll deliver precisely the quality you need.
Biotechnology

1991

L'Alliance Innovation Santé, ALLIS-NA, vise à regrouper l'ensemble des forces industrielles, académiques, institutionnelles et hospitalières autour de valeurs communes au profit des patients. Nos missions : Représenter et Animer l’Écosystème Santé en Nouvelle-Aquitaine pour soutenir son développement économique et Territorial : - Être un “partenaire” pour les professionnels d’innovation SANTE - Faciliter les connections et les alliances - Faire rayonner et représenter les professionnels de la filière - Accélérer la création de valeur et la croissance des entreprises N'hésitez pas à nous contacter et à rejoindre le réseau !
Biotechnology

2020

Tx Five - Biotech's Best Friend. We pride ourselves on supporting your journey from the company you are today to the company you aspire to be. Specialising in comprehensive biotech expansions across Europe and the US, we take a holistic approach to assess and enhance clinical and pre-clinical departments from the CxO level downwards, ensuring you stay ahead of your competitors. Our proven track record includes partnering with leading biotechs pioneering innovations such as ADCs, CAR-T therapies, small molecules, checkpoint inhibitors, cancer vaccines, and other groundbreaking drug types across critical therapeutic areas. Beyond our operational focus, we are dedicated to giving back. 5% of our fees are donated to charities aligned with our clients' missions, making a meaningful impact on patient communities. Partnering with us allows you to make a difference in biotech and beyond. Areas we excel in: - Oncology & Haematology - Neurosciences - Rare Diseases - Immunology - Cell & Gene Therapy Businesses we assist: - Small to mid-sized biotechs with ongoing studies from pre-clinical to Phase IV Communities we donate to: - Charities dear to our clients' hearts
Biotechnology

2023

As the UK’s leading open-access genomics service provider, Edinburgh Genomics is firmly established as the partner of choice for all your sequencing and bioinformatics needs. We produce high-quality, high volume data for a global community of research collaborators and customers across academia, government and industry. Embedded within the rich academic environment of the University of Edinburgh and drawing on world class expertise, we have a proven track record of delivering quality results to exacting standards. The Edinburgh Genomics teams have been delivering genomics data and analysis to researchers for nearly 20 years. Work enabled by Edinburgh Genomics has supported more than 1,300 peer-reviewed publications.
Biotechnology

2013

Analytik Jena is a leading global supplier of analytical measurement technology in the field of molecular biology as well as liquid handling and automation technology. Whether in the fields of chemistry, pharmaceuticals, medicine and life science, food safety, agriculture or environmental analysis - Analytik Jena offers standard-compliant applications for routine analysis as well as for special tasks. Precision, reliability, easy handling and comprehensive service are the top priorities in the development of laboratory analysis products. Analytik Jena is part of the Swiss Endress+Hauser Group. Visit our YouTube profile for moving footage >>> https://www.youtube.com/@analytik-jena
Biotechnology

1990

Depuis son fondement en janvier 2016, Woodlight est une Startup de recherche et développement de nouvelles biotechnologies. Son objectif est de rendre les villes plus vertes en répondant à leurs problèmes de pollution, de manque de verdure et de forte consommation en énergie. Pour répondre aux besoins grandissants d’éclairage durable et d’économie d’énergie des villes, Woodlight propose de développer un procédé permettant de rendre des plantes, bioluminescentes. Ces plantes pourront être utilisées comme lampes d’ambiance pour la décoration intérieure. On peut alors imaginer autant un lierre, qu’un ficus ou encore une orchidée luminescente. Au-delà de ces utilisations, ces plantes pourraient être utilisées comme alternative végétale aux lampadaires des villes ou comme balise dans des parcs et jardins. Les applications sont vastes et nous vous laissons imaginer leurs potentiels !
Biotechnology

2018

Gate2Brain is a biotech company focused on the development of therapeutics that efficiently cross biological barriers such as the blood-brain barrier. Gate2Brain pursues its goals using a radically innovative peptide-based patented technology platform. G2B-002, Gate2Brain flagship product and proof of concept of the technology, offers a new therapeutic approach with improved biopharmaceutical properties and potent activity against rare paediatric cancers.
Biotechnology

2020

Point-of-Care (POC) technologies, designed to provide rapid clinical diagnosis at, or near the site of patient care, has the potential to sense changes in well-known biomarkers used already to monitor patients with chronic cardiac and respiratory diseases. However, they need to be measured in blood, which limit their use only in medical institutions. Our non-invasive products based on wearable formats will empower the patients and their families to measure relevant biomarkers anytime and anywhere, allowing them to detect and monitor early stages of possible clinical deterioration, which could prelude in earlier (self-)management strategies, resulting in shorter hospital stays and prevention of unnecessary treatments. Our social impact will be a priority. Our challenge is addressed to patients of all ages, from neonates with congenital heart disease and bronchiolitis’, to the elderly with chronic heart failure due to myocardial infarction or chronic lung diseases and asthma. Our product offers continuous, non-invasive monitoring that have a positive health impact to the health deterioration. We will support active aging and improve the self-management of health.
Biotechnology

2016

Cellmark pioneered the introduction of DNA analysis for paternity testing. We deliver a next day service using the most conclusive 24 marker genetic test - across our range of DNA relationship testing services - that includes DNA testing for - Maternity, Sibling, Avuncular, Grandparentage and Immigration matters as well. If your samples reach us by 10am we can get the test report to you by the end of the next working day!
Biotechnology

1987

Epistem Ltd. is a leading contract service provider offering innovative preclinical research services, genetic and protein biomarker testing as well as histology services to pharmaceutical, biotech and academic customers to support to drug discovery and development pipelines. We have worked with over 200 pharmaceutical and biotechnology companies at both preclinical and clinical stages. Our high level of expertise and customer focus has led to an enviable track record and impressive amount of repeat business. Our preclinical contract research services group advance drug development programs for oncology, inflammatory, dermatology, auto-immune and GI disease indications. We offer an impressive range of preclinical models in these therapeutic areas. We also provide information relating to toxicity assessments and are experts in GI tox. We also offer a broad range of cell based assays including novel stem cell assays. Our biomarker services division offers GCLP compliant genetic testing, histology, FACS analysis and protein biomarker detection. Epistem’s genetics group offer gene expression and DNA genotyping sample analysis by NGS, microarray and qPCR. We specialise in working with small starting materials (down to a single cell input) applying our proprietary low input techniques and products to support drug development programs. We are specialists in fractionating cell populations and conducting genetic analysis. We have pioneered techniques using plucked scalp hair and laser capture microdissected material to provide gene expression biomarker information to drug development programs. Epistem is committed to provide reliable and innovative services to support all phases of drug development from to preclinical projects to clinical trials. Website: www.epsitem.co.uk
Biotechnology

2000

DD BioLab es un proveedor global de consumibles, equipos científicos, servicios y soluciones integradas para el laboratorio, centrado en el Mercado Ibérico. Compañía fundada en Febrero de 2014 y perteneciente al Grupo Dutscher, líder europeo en su mercado específico. Con una línea de productos altamente diversificada y dirigida tanto a los principales centros de investigación, desarrollo e innovación públicos y privados, que operan en los sectores de Investigación, Académico, Ciencias de la Vida, Químico, Farmacéutico, Biotecnológico, Industrial y de la Salud y la Seguridad; como a los laboratorios en general de cualquier sector industrial, con claro enfoque para el mercado Ibérico.
Biotechnology

2014

DNA Legal offer drug, alcohol, paternity, and forensic testing. We go to incredible lengths to help you find the truth, with hair strand testing for drugs and alcohol, legal paternity testing, relationship testing for immigration, forensic toxicology, and more. Our laboratories invest heavily in research, ensuring industry leading levels of sensitivity and accuracy. Because of this, DNA Legal offers the most detailed and wide ranging selection of testing available. But we won't stop at issuing your results - we assess and clearly explain the factors which underpin them. With a team that truly cares, we promise to support you at every step, from client care to expert witness testimony.
Biotechnology

2004

AHV International is an innovative knowledge centre and leading developer of the Animal Health Vision Concept. Through our services and solutions, we strive to connect and support our sector on an international level. It is our mission as a sector to work together. AHV therefore wants to proactively support and relieve livestock farmers, veterinarians and companies within agriculture. We do this by developing various supplementary animal feeds on a natural and scientific basis, which support the resistance and welfare of your animal, as well as by providing extensive, transparent and expert services. We believe that with our Animal Health Vision Concept and AHV Solutions, together as an industry, we can achieve better care results within the entire animal health continuum: from the health and welfare of your animals, to tailored advice, education and (pre- and post-) care. For today, tomorrow and the future, so that together we can ensure that you and following generations of dairy farmers remain the driving force behind our society.
Biotechnology

2014

We are a Cambridge-based company developing a radically different approach to gene synthesis. Our desktop DNA synthesis platform will provide the ability to synthesise DNA at unprecedented accuracy, scale and speed, accelerating scientists'​ ability to use synthetic biology on a scale not currently possible.
Biotechnology

2015

Mission: Deliver low-cost, non-invasive in vitro diagnostics (IVDs) for high-incidence diseases at the point-of-care. Approach: Using Raman Spectroscopy and Surface Enhanced Raman Spectroscopy (SERS) to achieve detection beyond current standard-of-care IVDs. Existing research supports identifying target diseases in urine using this approach. Focus: Serox has attracted a fantastic array of scientific and medical advisors and has established clinical relationships to help validate its approach, initially in bladder, prostate and kidney cancers. The intention is to ‘bundle’ tests which may be requested together, say when a patient presents with blood in their urine. Women’s cancers will follow, along with point-of-care speciation of Urinary Tract Infections. Differentiation: Serox displaces chemistry with photonics and Machine Learning, to allow urinalysis to avoid invasive procedures (blood taking, biopsy cystoscopy). Serox is following a data-focussed path that will lead to the personalisation of IVD. Timeliness: Raman Spectroscopy and SERS have long been used in advanced laboratories. The price of lasers and detectors is falling, and the usability and deployability of Raman Spectrometer improving. Machine Learning allows the ability to diagnose from the aggregate of Raman shifts in complex liquids. Together this unlocks the use of Raman Spectroscopy as a routine diagnostic. Outcome: Serox offers the prospect of a low-cost cartridge that be used remotely to acquire a urine sample, or in a clinic at the point-of-care, that can be processed using a desktop analyser in less than three minutes to provide an answer with a high Negative Predictive Value, and sensitivity / specificity in line with the current standard-of-care. This could reduce referrals to cystoscopy and biopsy, ultimately transform screening, and reduce the unnecessary use of broad-spectrum antimicrobials.
Biotechnology

2018

OPERON is a private Spanish company founded as a family business in 1973 engaged during the last 50 years in R&D innovation and manufacturing of In Vitro Diagnostics IVD. Active in the clinical diagnostics, in the veterinary field and in the food industry checking frauds in milk. The company is ISO 9001:2000 and ISO 13.485:2008 certified complying with cGMP . OPERON employs above 80 highly skilled and experienced people, 20 of them involved in R&D work. OPERON controls the whole added value chain of a new IVD test. Starting with the design of the raw materials, producing the kits and selling the IVD test to the end users through distributors or through its partners channels. OPERON is active in 4 different areas: 1. Lateral Flow Tests, more than 20 years experience. Working on a 3rd quantitative generation using fluorescent particles and a portable Point Of Care POC reading instrument. 2. Molecular Biology tests, based on different technologies: hybridization on strip (Opegen products), and Real Time PCR. All these products are based on the capture with specific probes of DNA fragments amplified by a conventional PCR. 3. Raw Materials: Develops Monoclonal Antibodies and Recombinant Antigens and produces them also in bioreactors and fermentors at industrial scale. 4. All our know how is available as a service. Development of new Monoclonal Antibodies and Recombinant Antigens, large scale production, purification. The development of innovative IVD tests is our most challenging task. Exporting more than 90% of its turnover mainly to Europe, US, Japan and 50 more countries. OPERON currently sells its brand name products using a network of distributors around the world, but our largest activity is to manufacture OEM kits or to supply in bulk to leading companies in the IVD sector.
Biotechnology

1973

Spur Therapeutics (formerly Freeline Therapeutics) is a clinical-stage biotechnology company focused on developing life-changing therapies for debilitating chronic conditions. By optimizing every component of our product candidates, we are improving genetic expression and targeted delivery to realize outsized clinical results. Building on the successes of our two potential first-in-class therapies for Gaucher disease and adrenomyeloneuropathy (AMN), we’re moving from rare diseases toward more widespread conditions, including forms of Parkinson’s and dementia, and even certain cardiovascular diseases. Expanding our impact, and pushing forward to new frontiers of genetic medicine. Toward life-changing therapies, and brighter futures. Toward More™
Biotechnology

2015

By mining the genome using our bioinformatics platform we discover and re-purpose natural gene regulatory elements, creating customised gene expression systems to: 1. Improve human health: Creating highly selective and controllable promoters and gene expression cassettes for novel gene and cell therapy systems. Improving the efficiency of biologics production by increasing protein yields in upstream manufacturing processes. 2. Engineer biology: Harnessing synthetic biology to make promoters for a wide array of chassis organisms used in Industrial Biotech. Creating switches and gene circuits that can be employed in the metabolic engineering applications. 3. Enable traits discovery: Designing tissue-selective plant synthetic promoters active across different crop species for Agricultural Biotech applications. Using plant genomics to facilitate the design of environmentally-regulated and pathogen-responsive promoters.
Biotechnology

2022

STORM Therapeutics is a biotechnology company creating novel therapies that inhibit RNA modifying enzymes (RME) for use in oncology and other diseases. There are more than 150 RNA modifications reported and approximately 300 RNA modifying enzymes which represent novel therapeutic targets. STORM has leveraged its first mover advantage to establish a novel drug discovery and RNA analytics platform leading to the identification of novel targets and a proprietary pipeline of first in class small-molecule drug candidates for potential use in oncology, inflammation, viral infections, and CNS diseases. The pipeline is exemplified by STORM’s METTL3 inhibitor (STC-15) for which an IND has been filed with the FDA to support initiation of a Phase I clinical trial in cancer patients in 2022. STC-15 represents the first RNA modifying enzyme inhibitor to enter clinical evaluation in humans. Additional candidates are planned for advancement into IND-track activities in 2023. STORM has built an experienced R&D team who occupy modern, well-equipped laboratories on the Babraham Research Campus near Cambridge, UK. The company’s proprietary in house research is complemented by outsourcing of some discovery activities to high quality CRO partners (e.g., Evotec) enabling STORM to operate a cost efficient and flexible model.
Biotechnology

2015

Sterilab Services is a specialist diagnostic company dedicated to providing high quality solutions for healthcare professionals. Our products are widely used in the UK-in NHS and private sector hospitals, clinical laboratories, physician’s offices and other healthcare facilities. They can be found in both centralized laboratories and at the point of care. We work with leading international diagnostic companies in four main business areas: urinalysis, infectious disease, sample collection and transport and storage. Sterilab Services is a specialist diagnostic company dedicated to providing high quality solutions for healthcare professionals. Our products are widely used in the UK-in NHS and private sector hospitals, clinical laboratories, physician’s offices and other healthcare facilities. They can be found in both centralized laboratories and at the point of care. We work with leading international diagnostic companies in four main business areas: urinalysis, infectious disease, sample collection and transport and storage. Sterilab is committed to offer products of leading quality and design - which consistently meet or exceed the needs and expectations of the professionals we serve. We have a strong focus on continuous improvement and maintain an integrated Quality and service Management System (QMS) to deliver on this commitment Sterilab is committed to offer products of leading quality and design - which consistently meet or exceed the needs and expectations of the professionals we serve. This commitment is achieved through listening to our customers, bringing together proven manufacturers and systems to translate customer needs into innovative and reliable diagnostic solutions. We have a strong focus on continuous improvement and maintain an integrated Quality and service Management System (QMS) to deliver on this commitment
Biotechnology

2000

XenTech is Biotech/Contract Research Organization (CRO) dedicated to translational research in oncology which offers preclinical services to evaluate the anti-cancer potential of drug candidates (PDX, CDX,...) In addition, XenTech develops internal R&D programs to correlate drug response with molecular features of tumors and identify cancer biomarkers and therapeutic targets.
Biotechnology

2006

BioMedha is a UK-based pre-clinical CRO providing in vitro biology expertise to the global drug discovery industry. We are industry-experienced, in vitro biology-focused scientists and can add significant value to our client programmes by undertaking key elements of the early stage drug discovery process. BioMedha expertise includes: • HTA authorized establishment with on-site blood donor panel • Immunology, Oncology, Immuno-oncology, and inflammation studies • Target validation, assay development, screening, and MOA studies • Whole blood and Immune cell functional assays • Flow cytometry capabilities • Cytokine assays and Luminex multiplexing • Cell imaging expertise • Expression studies (protein levels, mRNA levels, and surface expression) • Plate reader-based assays (Fluorescence, Luminesce, Absorbance, FP, FRET, BRET, Alphascreen, HTRF) • Functional assays (e.g. signalling pathways, bioassays) • GPCRs: assay development and screening • Protein-Protein Interactions (PPI) • Enzyme activity • Discovery Toxicology studies We are a small but passionate team of scientists with substantial experience in the pharmaceutical and biotech industries, focused heavily on pre-clinical drug discovery biology. We serve clients in pharma, biotech, virtual companies, spin-outs, and academic institutions.
Biotechnology

2015

Haier Biomedical provides innovative, robust and sustainable products and services to the life science sector. We help organisations with their challenges by offering market-led, low-impact, quality and technologically-advanced products, which are trusted by scientists globally. As the local hub for Haier Biomedical our approach is to build partnerships with our clients, providing a personal touch, going the extra-mile and delivering value.
Biotechnology

2016

Barinthus Biotherapeutics is a clinical-stage biopharmaceutical company developing novel T cell immunotherapeutic candidates designed to guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. Helping people living with serious diseases and their families is the guiding principle at the heart of Barinthus Biotherapeutics. With a broad pipeline, built around four proprietary platform technologies: ChAdOx, MVA, SNAP-TI, and SNAP-CI; Barinthus Biotherapeutics is advancing a pipeline of five product candidates across a diverse range of therapeutic areas, including: VTP-300, an immunotherapeutic candidate designed as a potential component of a functional cure for chronic HBV infection; VTP-1000, an autoimmune candidate designed to utilize the SNAP-TI platform to treat patients with celiac disease; and VTP-850, a second-generation immunotherapeutic candidate designed to treat recurrent prostate cancer. Barinthus Biotherapeutics’ proven scientific expertise, diverse portfolio and focus on pipeline development uniquely positions the company to navigate towards delivering treatments for people with infectious diseases, autoimmunity and cancers that have a significant impact on their everyday lives.
Biotechnology

2016

Founded in 2004 and headquartered in Warrington, Cheshire, AlphaBiolabs is a leading and award-winning provider of DNA, drug, alcohol, and health testing services across the UK. We employ state-of-the-art techniques to provide timely, accurate, and cost-efficient testing to meet a range of needs. Our client base includes businesses of all sizes across every sector, family and immigration law solicitors, social services, local authorities, members of the public, and the media. Our laboratory is accredited to the international quality standards UKAS ISO 17025 and ISO 9001, and our test results are accepted by the Ministry of Justice, the Home Office, UK Visas and Immigration, HM Passport Office, Border Force, and Immigration Enforcement. We also operate a network of walk-in centres in 21 locations across the UK and Ireland.
Biotechnology

2004

Astell Scientific has been a world leading manufacturer and supplier of laboratory, pharmaceutical & hospital autoclaves and sterilizers for over a century, shipping thousands of autoclaves around the world. Through continuing investment in product development and information technology, Astell Scientific offers high quality products manufactured in the UK and backed up by efficient order processing and prompt dispatch. During the last twenty years Astell Scientific have developed a reputation as specialist manufacturers of sterilization equipment, producing a wide range of front and top-loading PLC controlled Autoclaves and Sterilizers designed to meet the exacting demands of the modern Laboratory, Pharmaceutical and Medical professionals. All Astell Scientific autoclaves, Steam Generators and Effluent Decontamination systems (EDS) incorporate the latest innovations in control system technology, providing colour touchscreen controllers, on screen tutorial, 5 password levels, multiple cycle programming, secure data archiving, and delayed start facility all included as standard throughout the range. These include: Circular section units from 30-330 litres Square Section units from 125 - 2000 litres Steam Generators up to 72 kW Effluent Decontamination Systems (EDS) designed to your needs Other items we produce: Nelldorn Glassware Dryers Hearson Tobacco Ovens #autoclave #sterilizer #sterilisation
Biotechnology

1884

Talent Consultancy -Understanding people, using our approach, enables you to determine how well your staff are engaged, help them to think through their career and put in place succession and people expansion plans. Coaching - I provide you with an opportunity to evaluate your unique contribution in the workplace, work effectively in teams and explore how to make the most of your career. Team Coaching -We use group online sessions to build respect and trust within and between small teams. Everyone is brilliant; we just need to understand how these skills can best be utilised. Senior Recruitment -We can deliver senior level executive search assignments built on a strong understanding of your organisation. This is done with our recruitment partner - Horton International.
Biotechnology

2015

List of Biotechnology companies in Europe

Company Name

Location

Category

Employees

Website

Monheim am Rhein, Germany

Science and Engineering
Science and Engineering

50-100

http://www.resolvebiosciences.com

Alcorcón, Spain

Science and Engineering
Science and Engineering

100-150

https://www.natacgroup.com

Nottingham, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

https://cellomaticsbio.com/

High Peak, United Kingdom (UK)

Science and Engineering
Science and Engineering

200-500

http://www.conceptlifesciences.com

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

https://multus.bio

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://eden.bio/

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

http://www.kyomei.co.uk

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://plurify.bio

Oxfordshire, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://iuvantium.com

Newcastle Upon Tyne, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://kerato.co.uk

Nottingham, United Kingdom (UK)

Science and Engineering
Science and Engineering

50-100

http://www.futurehealthbiobank.com

Leatherhead, United Kingdom (UK)

Science and Engineering
Science and Engineering

50-100

https://www.photophysics.com/

Köln, Germany

Science and Engineering
Science and Engineering

20-30

https://cellbox-solutions.com/

LEIDEN, The Netherlands

Science and Engineering
Science and Engineering

2-10

http://matresearch.com

Odense, Denmark

Science and Engineering
Science and Engineering

50-100

http://www.pentabase.com

Copenhagen, Denmark

Science and Engineering
Science and Engineering

2-10

http://unseenbio.com

Ljubljana, Slovenia

Science and Engineering
Science and Engineering

20-30

http://www.aciesbio.com

Nordhavn, Denmark

Science and Engineering
Science and Engineering

20-30

http://abzu.ai

Kirtlington, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

http://www.2bscientific.com

Madrid, Spain

Science and Engineering
Science and Engineering

10-20

https://www.bio-cord.es

Roma, Italy

Science and Engineering
Science and Engineering

2-10

https://genes4you.it/

Utrecht, The Netherlands

Science and Engineering
Science and Engineering

20-30

http://www.scdiscoveries.com

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

http://www.antibodies.com

Nottingham, United Kingdom (UK)

Science and Engineering
Science and Engineering

100-150

https://www.scientificlabs.co.uk

Pessac, France

Science and Engineering
Science and Engineering

2-10

https://allis-na.fr

London, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://www.txfive.com/

Edinburgh, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

https://genomics.ed.ac.uk

Jena, Germany

Science and Engineering
Science and Engineering

1000-5000

https://www.analytik-jena.com/

Illkirch-Graffenstaden, France

Science and Engineering
Science and Engineering

2-10

https://woodlight.fr/

Barcelona, Spain

Science and Engineering
Science and Engineering

2-10

http://www.gate2brain.com

Barcelona, Spain

Science and Engineering
Science and Engineering

20-30

http://www.onalabs.com

Abingdon, United Kingdom (UK)

Science and Engineering
Science and Engineering

200-500

https://www.cellmark.co.uk/

Manchester, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

http://www.epistem.co.uk

Barcelona, Spain

Science and Engineering
Science and Engineering

200-500

http://www.ddbiolab.com

Frome, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

http://www.dnalegal.com

Zwolle, The Netherlands

Science and Engineering
Science and Engineering

200-500

http://www.ahvint.com

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

50-100

http://www.evonetix.com

Long Hanborough, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

https://www.serox.ai

Cuarte de Huerva, Spain

Science and Engineering
Science and Engineering

50-100

http://www.operondx.com

Stevenage, United Kingdom (UK)

Science and Engineering
Science and Engineering

100-150

http://www.spurtherapeutics.com

Edinburgh, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

http://www.chromatinbio.com

Cambridge, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

http://www.stormtherapeutics.com

Wetherby, United Kingdom (UK)

Science and Engineering
Science and Engineering

10-20

http://www.sterilab.co.uk/

Evry, France

Science and Engineering
Science and Engineering

20-30

http://www.xentech.eu

Nottingham, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

https://biomedha.com

Sunbury on Thames, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

http://www.haierbiomedical.co.uk/

Harwell, United Kingdom (UK)

Science and Engineering
Science and Engineering

100-150

https://www.barinthusbio.com

Warrington, United Kingdom (UK)

Science and Engineering
Science and Engineering

100-150

http://www.alphabiolabs.co.uk

Sidcup, United Kingdom (UK)

Science and Engineering
Science and Engineering

20-30

https://www.astell.com

Bristol, United Kingdom (UK)

Science and Engineering
Science and Engineering

2-10

http://www.biosocius.com

250/480 results

Frequently asked questions

Updated 23 October 2026

What is Enterprise League?

Enterprise League is a free business directory that helps buyers find the right company by sector and country. Every company has a profile showing what it does, what it offers and how to get in touch.

Is it free to list my company?

Yes, and it stays free: no card, no paid tier. Your profile appears in search results and category pages, can show up to 20 products and services, and lets buyers message you or ask for a quote.

How does verification work, and what does it cost?

Verifying your company is free. Confirm a code we email to an address at your company’s website, or send a company registration document for our team to check, and the verified badge appears on your profile. To show the badge in the directory and search results as well, take out a subscription: the first 14 days are free, and the price is on our pricing page.

Where does the company information come from?

Most profiles are built from public sources, such as official company registers. Claim your company’s profile to correct its details and add your own.

How do I claim or correct my company’s profile?

Open your company’s profile and choose Claim Profile. If you use an email address at your company’s website, a 6-digit code makes the profile yours at once; otherwise our team reviews your request, usually within a few days. Spotted a mistake on a company that isn’t yours? Tell us through our contact page.